1. [PDF] Nederland De industriele eigendom Nummer 21/22
7 Heading NP1. 7. Contains data concerning Netherlands patent applications which have been entered in the patent register under the. Patents Act 1995. 13 ...
2. The Official Gundam: The Witch From Mercury Mecha Thread Mk I - Page 3
4 okt 2022 · Takayuki Yanase and Kenji Teraoka work on designs for other MS and ... They were no visible implants on her dad and and the other person but they ...
Post Reply
3. Identification and Characterization of Prokaryotic Dipeptidyl-peptidase 5 ...
Background: Dipeptidyl-peptidases (DPPs) are key factors for amino acid metabolism and bacterial growth of asaccharolytic Porphyromonas gingivalis.
Background: Dipeptidyl-peptidases (DPPs) are key factors for amino acid metabolism and bacterial growth of asaccharolytic Porphyromonas gingivalis. Results: DPP5, which is specific for Ala and hydrophobic residues, is expressed in the periplasmic ...
4. ARISE | Ghost in the Shell Official Global Site - 攻殻機動隊
Extensively enhanced, most of his body has been replaced with cybernetics, and he possesses implants known as the "Sleepless Eye." His numerous battles have ...
An official global source for all the info you could want about the Ghost in the Shell series!
5. Suzukake Science Day 2022 held in hybrid format - 東京工業大学
13 jul 2022 · Professor Yanase. On May 14, author and Tokyo Tech Professor Hiroichi Yanase gave a lecture on "Route 16 and Japan ...
Suzukake Science Day 2022, an open-day event for children, prospective students, and other members of the public which focuses on activities on Tokyo Tech's Suzukakedai Campus, was successfully held i...
6. Takayuki Yanase | Metal Gear Wiki - Fandom
Bevat niet: implants | Resultaten tonen met:implants
Takayuki Yanase (柳瀬 敬之, Yanase Takayuki?, born January 21, 1978) is a Japanese illustrator known primarily as a mecha designer on various video game and anime projects. He was first employed by Square Soft in 1997 as a part-time mecha and motion designer, working on titles such as Tobal 2, Ehrgeiz and The Bouncer. After leaving Square, he joined From Software in 1999 and worked as a mecha designer on Armored Core II, Armored Core II: Another Age and Murakumo: Renegade Mech Pursuit. Following his
7. [PDF] Hoofdblad IE 20 april 2022
20 apr 2022 · 10 Heading NP2. 10. Contains data concerning Netherlands patents which have been entered in the patent register under the Patents Act. 1995. 13 ...
8. Journal of Japanese Society of Oral Implantology - J-Stage
Shinya Tajima, Akio Takimoto, Takayuki Jitou, Makoto Minamimoto, Keiha ... ... implants following reconstructive surgery with iliac bone graft was reported.
Published by Japanese Society of Oral Implantology. FREE ACCESS
9. Details of a Researcher - FUJITA TOMOYUKI - 東京医科歯科大学
FUJITA TOMOYUKI. Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Cardiovascular Surgery. Personnel ...
Amano M, Takegami M, Miyake M, Kitai T, Fujita T, Koyama T, Tanaka H, Ando K, Komiya T, Izumo M, Kawai H, Eishi K, Yoshida K, Kimura T, Nawada R, Sakamoto T, Shibata Y, Fukui T, Minatoya K, Tsujita K, Sakata Y, Sugio K, Nishimura K, Furukawa Y, Izumi C; BPV-AF Registry Group. Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation. Int J Cardiol. 2024.07; ( PubMed, DOI )
10. Kotobukiya FAG Kongou [Plastic Model] [Resale] "Frame Arms Girl"
Frame Arms Kongou, designed by Yanase Takayuki, has been made into a three ... Frame Arms' distinctive 3mm holes in various parts and PVC wrists make ...
Kotobukiya's original content, Frame Arms Girl Kongou, is finally here! Frame Arms Kongou, designed by Yanase Takayuki, has been made into a three-dimensional figure based on the beautiful girl illustration by Shimada Fumikane! [Product Specifications] ・This is a completely new Frame Arms Girl. -Large weapons can be tr
11. Long-term efficacy and safety of difelikefalin in moderate-to-severe ...
19 jul 2024 · This was a 52-week, open-label phase 3 trial following a 6-week randomized double-blind placebo-controlled treatment period to investigate the ...
Difelikefalin, a potent and highly selective agonist of kappa opioid receptors, is used to treat moderate-to-severe pruritus in hemodialysis patients. This was a 52-week, open-label phase 3 trial following a 6-week randomized double-blind placebo-controlled treatment period to investigate the efficacy and safety of difelikefalin in Japanese hemodialysis patients. Having completed the 6-week double-blind period, patients received difelikefalin 0.5 μg/kg three times per week intravenously for 52 weeks. Efficacies were assessed using numerical rating scale (NRS) scores, proportion of patients whose NRS score improved by ≥ 3 points and ≥ 4 points, Shiratori severity score, proportion of patients with a nighttime Shiratori severity score of ≤ 2, the Skindex-16 score, 5-D itch scale score, and patient global impression of change (PGIC). Safety was assessed on the basis of adverse events, clinical laboratory tests, vital signs, body weight, 12-lead electrocardiography, and dependency. The number of patients who entered the extension treatment period from the difelikefalin (MR–MR) and placebo (P-MR) groups was 85 and 83, respectively. The weekly mean NRS scores (mean ± SD) in the MR–MR group at baseline, week 6, and week 58 were 6.57 ± 1.32, 4.04 ± 2.24, and 2.36 ± 1.86, respectively. The weekly mean scores in the P-MR group, at baseline, week 6, and week 58 were 6.42 ± 1.29, 4.85 ± 1.90, and 2.73 ± 2.14, respectively. In patients receiving difelikefalin, there was a declin...